DOCSLIB.ORG

Abstract Funding Sources* AGA Oral and Poster Presentations at DDW

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Abstract Funding Sources* AGA Oral and Poster Presentations at DDW Abstract Funding Sources* AGA Oral and Poster Presentations at DDW® 2019 AGA Institute 4930 Del Ray Avenue Bethesda, MD 20814 301.654.2055 (National Office) 301.654.3978 (Fax) * Information contained in this report www.gastro.org is current as of April 22, 2019. AGA Oral Presentations 1. HUMAN INDUCED PLURIPOTENT 21. EFFICACY AND SAFETY OF 41. THE DUTCH AMERICAN RISK STEM CELL-DERIVED MESENCHYMAL… (2*) URSODEOXYCHOLIC ACID… STRATIFICATION TOOL… (5*) (3*)|(Daewoong Pharmaceutical Co., Ltd.) 2. STEM CELL-DERIVED 3D ORGANOIDS 42. THIOPURINE METABOLITE LEVELS RECAPITULATE FEATURES… (2*) 22. CAN CHOLECYSTITIS BE AN IN PREGNANT IBD… (4*)|(6) ADVERSE EVENT… (5*) 3. A NEW FORM OF HUMAN 43. PREGNANCY OUTCOMES IN ROTAVIRUS… (2*) 23. BILIARY DILATION IN PATIENTS INFLAMMATORY BOWEL DISEASE… (5*) WITH NORMAL… (2*)|(4) 4. FIRST LARGE SCALE STUDY DEFINING 44. INFLIXIMAB CLEARANCE IS THE… (4*) 24. TIMING OF CHOLECYSTECTOMY DECREASED DURING 2ND… (1*) AFTER ACUTE BILIARY… (5*) 5. MICROBIOTA-DEPENDENT 45. LONG-TERM OUTCOMES OF IN- BEHAVIORAL ABNORMALITIES IN THE 25. UNDERLYING EATING DISORDER UTERO EXPOSURE TO… (6*) ZONULIN… (2*) PATHOLOGY IN CHRONIC… (5*) 46. SAFETY OF FLEXIBLE 6. INTESTINAL MICROBIAL FUNCTIONAL 26. THE EFFECT OF RECREATIONAL SIGMOIDOSCOPY IN PREGNANT… (5*) CONTENT BETTER DEFINES… (4*)|(2) MARIJUANA USE… (7*)|(2) 85. SIRT2 REGULATES INTESTINAL CELL 7. THE ICON STUDY: INFLAMMATORY 27. TRANSLUMBOSACRAL PROLIFERATION AND… (2*) BOWEL DISEASE… (6*)|(2) NEUROMODULATION THERAPY FOR FECAL INCONTINENCE:… (2*) 86. HEAT SHOCK PROTEIN GP96 IS 8. POPULATION-SCALE MICROBIOME ESSENTIAL… (4*) ANALYSIS DEFINES A NEW… (2*) 28. DEFECATORY FUNCTION TESTING IN FI PATIENTS… (2*) 87. MIR-181A-5P CONTRIBUTES TO 9. PREVALENCE AND PREDICTORS OF INTESTINAL CELL DIFFERENTIATION… (2*) GERD AND… (3*)|(Ironwood 29. RESTORATION OF FECAL Pharmaceuticals) CONTINENCE IN A… (6*) 89. MULTITARGET STOOL DNA TESTING AS ALTERNATIVE… (6*) 10. EFFECT OF RECENTLY DESCRIBED 30. NORMAL VALUES FOR ANORECTAL ADVERSE EVENTS… (5*) PRESSURES MEASURED… 90. POST-COLONOSCOPY MORTALITY (2*)|(3)|(Medspira Inc) IN A FIT-BASED COLORECTAL… (2*) 11. THE EFFECT OF REBAMIPIDE IN PATIENTS… (3*)|(Korea Otsuka 31. ENDOSOMAL SNX17 SETS THE 91. INTERVAL CANCERS AFTER A Pharmaceutical Co., Ltd.) PLASMA MEMBRANE… (2*) NEGATIVE FAECAL… (2*) 12. IMPACT OF IW-3718, A NOVEL 32. UNIQUE REGULATION OF 92. COMPARING THE COST- GASTRIC-RETENTIVE… (3*)|(Ironwood INTESTINAL EPITHELIAL CELL… (2*) EFFECTIVENESS OF NEW COLORECTAL… Pharmaceuticals) (2*) 33. GLP-2 INCREASES ELECTROGENIC 13. ANTIREFLUX SURGERY WITHIN SIX ANION SECRETION AND… (2*)|(3)|(Shire 93. FACTORS ASSOCIATED WITH THE MONTHS AFTER… (5*) Pharmaceuticals) PROGRESSION OF… (7*)|(4) 14. PANCREATIC AND HEMATOPOIETIC 34. E.COLI HEAT STABLE ENTEROTOXIN 94. SYSTEMATIC SCREENING PROTOCOL CALCINEURIN INDEPENDENTLY MEDIATE… (ST) INHIBITION… (2*)|(6) FOR THE STOMACH… (2*) (2*) 35. SHIGELLA GASTROENTERITIS 95. SERUM PROTEOMIC PROFILING IN 15. SOLUTE TRANSPORTER SLC26A9 TARGETS INTESTINAL URATE ULCERATIVE COLITIS… (4*) LOCALIZES TO THE… (2*) TRANSPORTER… (2*) 96. INCREASED INTESTINAL 16. IMMUNE PROFILING OF THE 36. GLUCOCORTICOIDS AND SGK1- PERMEABILITY IS A PREDICTOR… (6*)|(2) HUMAN PANCREAS… (2*) POTENT REGULATORS OF… (2*) 97. INCREASED RISK OF ULCERATIVE 17. DYNAMIC ASSOCIATION OF 37. METHYLATION CHANGES AT THE COLITIS IN… (5*) SYSTEMIC INFLAMMATION, GUT… (2*) GNAS IMPRINTED… (7*) 98. HORMONE THERAPY FOR CANCER 18. ROLE OF SONIC HEDGEHOG 38. ENDOSCOPIC ULTRASOUND- IS A… (6*)|(The Chemotherapy Foundation, PATHWAY IN… (2*)|(5) GUIDED FINE NEEDLE BIOPSY HAS… (5*) philanthropic organization) 19. KRÜPPEL-LIKE FACTOR 5 PLAYS AN 39. AGE, OBESITY, DIABETES AND 99. INFLAMMATORY BOWEL DISEASE IMPORTANT… (4*) INITIAL CYST… (5*) IN UK PRIMARY… (6*) 20. TRANSCRIPTOME ANALYSIS 40. TRIACYLGLYCEROLS AS A MARKER 100. LONGITUDINAL CHANGES IN THE DURING PROGRESSION OF CHRONIC… FOR CHARACTERIZATION… (2*) DIRECT COSTS… (6*)|(Crohn's and Colitis (4*)|(Nil) Cada) Abstract Funding Source Key * = Primary Source (1) = Clinical Practice Funds (2) = Government (e.g. NIH, CDC, Health Ministry, etc.) (3) = Industry or Commercial Entity (4) = Institutional Funds (5) = No Study Funding (6) = Philanthropic Organization (e.g. ALF, CCFA, etc.) (7) = Professional Organization (e.g. AGA, AASLD, etc.) 101. INCREASED EXPRESSION OF 121. HIGH CONTENT MORPHOLOGICAL 163. METFORMIN AND BET INHIBITORS MELATONIN IN THE… (2*) ANALYSES OF ESOPHAGEAL… (2*)|(4) REDUCE PROLIFERATION… (2*) 102. PHYSIOLOGICAL AND PROTEOMIC 122. CALPONIN-HOMOLOGY AND 164. ESTABLISHMENT OF A CHARACTERIZATION OF MICROTUBULE-ASSOCIATED PROTEIN NOMOGRAM COMPRISING OF… (2*)|(4) CAMPYLOBACTER… (2*)|(NIH K23 INTERACTS WITH… (2*) DK103911) 165. DEVELOPMENT OF THE 144. POSTOPERATIVE ENDOSCOPIC EOSINOPHILIC GASTRITIS MOLECULAR… 103. BENEFICIAL EFFECTS OF A LOCALLY AND CLINICAL RECURRENCE AFTER… (2*)|(CEGIR (U54 AI117804) is part of the ADMINISTERED… (2*)|(4) (6*)|(7) Rare Disease Clinical Research Network, an initiative of the Office of Rare Diseases 104. ASSOCIATIONS BETWEEN FECAL 145. INFLAMMATORY POTENTIAL OF Research, NCATS, and is funded through SHORT CHAIN FATTY… (4*) DIET IS NOT… (2*) collaboration between NIAID, NIDDK, and NCATS. CEGIR is also supported by patient 105. SACCHAROMYCES BOULARDII, A 146. GUT MICROBIAL DYSBIOSIS advocacy grou) YEAST PROBIOTIC, REGULATES… (5*) CONTRIBUTES TO FATIGUE… (6*)|(3) 166. L-TYPE CALCIUM CHANNEL 106. ALTERED GENDER DIFFERENCE IN 147. PEPT1 ENHANCED BACTERIAL INHIBITORS (VERAPAMIL AND… (4*) BRAIN HISTAMINE… (2*) PEPTIDE TRANSPORT INTO… (2*) 167. EOE ESOPHAGEAL EPITHELIAL 107. DISCONTINUITY OF CARE AMONG 148. SLC7A5 IS CRUCIAL FOR CELLS INDUCE TH2… (4*)|(2) INFLAMMATORY BOWEL… (5*) MAITENANCE OF… (2*) 168. EPIGENETIC ANALYSIS INDICATES 108. THE PREVALENCE AND USE OF 149. IN-DEPTH CHARACTERIZATION OF ACCELERATED MOLECULAR AGEING… (5*) CANNABIS… (5*) HOST-GENETICS AND GUT… (4*)|(2) 169. INTERLEUKIN-13-MEDIATED 109. ORAL VANCOMYCIN INDUCES AND 150. SINGLE-CELL ANALYSIS OF T CELL RELEASE OF MITOCHONDRIAL DNA MAINTAINS REMISSION… (5*) PATHOGENESIS… (4*) FROM… (2*)|(3)|(Shire) 110. STOPPING 5-AMINOSALICYLATES 151. USING DEEPLEARNING AND 202. THE MICROBIAL METABOLITE IN CROHN'S DISEASE PATIENTS… (6*) GENETIC BIGDATA TO… (2*)|(6) BUTYRATE PROMOTES GOBLET… (2*) 111. INCREASING VACCINATION RATES 152. PENTOXIFYLLINE TREATMENT IN 203. COLONIC MESENCHYMAL WITH A PATIENT… (5*) ACUTE PANCREATITIS: FEASIBILITY… (2*) STROMAL CELL MYD88-MEDIATED SIGNALING… (2*) 112. TELEPHONE STRAIGHT-TO-TEST 153. CORONIN 1 IS NECESSARY FOR M… (TSTT) IMPROVES EARLY DIAGNOSIS… (5*) (2*) 204. SURGERY IN VERY EARLY ONSET INFLAMMATORY… (6*) 113. HIGHER RESILIENCE IS 154. GUT MICROBE-PRODUCED SHORT ASSOCIATED WITH DECREASED… (5*) CHAIN FATTY ACIDS… (2*)|(4) 205. COLLEGE ADJUSTMENT IN IBD STUDENTS: AGE… (3*)|(Abbvie Inc.) 114. TISSUE-ENGINEERED INTESTINES 155. PRIMARY AND PLURIPOTENT CAN NEO-INNERVATE EXPERIMENTALLY STEM CELL DERIVED… (2*)|(4) 206. INCREASED EMERGENCY DENERVATED… (2*) DEPARTMENT VISITS AND 156. H. PYLORI INDUCES GASTRIC HOSPITALIZATIONS… (2*)|(6) 115. TRANSCUTANEOUS AURICULAR EPITHELIAL CELL… (2*) VAGAL NERVE STIMULATION IMPROVES… 207. INCREASED INCIDENCE OF (5*) 157. THE INTESTINAL MALIGNANCY IN PATIENTS… (2*)|(6) MICROENVIRONMENT INDUCES A 116. ELECTROGASTOGRAPHY AT TRANSCRIPTION… (4*) 208. SAFETY AND EFFICACY OF ANTI- BASELINE AND RESPONSE TO… (5*) TNF THERAPY… (5*) 158. LEVERAGING HUMAN INTESTINAL 117. SYNDAPIN 2 IS REQUIRED FOR ORGANOIDS TO ADVANCE… (3*)|(AbbVie) 209. EARLY COMBINED MICROVILLUS… (2*) IMMUNOSUPPRESSION IS EFFECTIVE 159. ALDH1A3 PROMOTES METASTATIC AND… (2*) 118. ACTIVATION OF THE UNFOLDED COLONISATION OF PANCREATIC… (2*) PROTEIN RESPONSE… (2*) 235. EARLY INFLIXIMAB 160. DELETION OF NRF2 IN PHARMACOKINETICS AND WEEK ONE… 119. RNA-BINDING PROTEIN HUR PANCREATIC STELLATE… (5*) (6*)|(2)|(Prometheus Labortories, REGULATES AUTOPHAGY ACTIVITY… (2*) Inc.provided study assay.) 161. PANCREATIC ACINAR CELL 120. MITOCHONDRIAL IMPAIRMENT IN REPROGRAMMING INDUCED BY… (2*) 236. ADOLESCENTS' AND YOUNG CROHN'S DISEASE-LIKE INFLAMMATION… ADULTS' SATISFACTION WITH… (5*) (2*) 162. GLYCEMIC PROFILE OF SUBJECTS WITH FAMILIAL… (5*) 237. GEOGRAPHIC ANALYSIS OF PEDIATRIC INFLAMMATORY BOWEL… (5*) Abstract Funding Source Key * = Primary Source (1) = Clinical Practice Funds (2) = Government (e.g. NIH, CDC, Health Ministry, etc.) (3) = Industry or Commercial Entity (4) = Institutional Funds (5) = No Study Funding (6) = Philanthropic Organization (e.g. ALF, CCFA, etc.) (7) = Professional Organization (e.g. AGA, AASLD, etc.) 270. ESOPHAGEAL HYPERVIGILANCE 302. EARLY CHANGE IN FECAL 238. NUCLEIC ACID AMPLIFICATION AND SYMPTOM ANXIETY ARE… (2*) CALPROTECTIN PREDICTS… (2*)|(4) FOLLOWED BY ENZYME… (2*) 271. MANAGEMENT OF SUPRA- 303. EFFECT OF A PRACTICE-WIDE ANTI- 251. ENDOSCOPIST-RELATED FACTORS GASTRIC BELCHING WITH COGNITIVE… (1*) TNF THERAPEUTIC… (2*)|(4) INFLUENCING POLYP DETECTION RATE… (5*)|(The first author completed this 272. AVOIDANT/RESTRICTIVE FOOD 304. NEW KEY PLAYERS IN IMPAIRED research during a Newman Fellowship INTAKE DISORDER AMONG ADULT… (5*) ANGIOGENESIS… (2*) programme, sponsored by Boston Scientific) 273. A MULTIDISCIPLINARY 305. GENERATION OF STRATIFIED 252. A PROSPECTIVE RANDOMIZED INTEGRATED TREATMENT APPROACH IS… ESOPHAGEAL EPITHELIUM FROM… (6*) TANDEM COLONOSCOPY STUDY… (2*) (4*)|(Nil) 306. CELLS LINEAGE TRACED FROM 274. VARIATION IN ADENOMA LGR5+ CELLS… (2*) 253. THE POLYP-BASED RESECT-AND- DETECTION RATE AND… (2*) DISCARD STRATEGY: A PROSPECTIVE… (5*) 307. PROTEOMIC ANALYSIS OF 275. DETERMINATION
Load more

Recommended publications
  • Is Pylorus Resecting Pancreaticoduodenectomy a Better Surgical Alternative Than Pylorus Preserving Pancreaticoduodenectomy Regarding Delayed Gastric Emptying?
    Editorial Page 1 of 3 Is pylorus resecting pancreaticoduodenectomy a better surgical alternative than pylorus preserving pancreaticoduodenectomy regarding delayed gastric emptying? Shengliang He, Jin He Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Correspondence to: Jin He, MD, PhD, FACS. Department of Surgery, Johns Hopkins Hospital, 600 N. Wolfe Street, Blalock 665, Baltimore, MD 21287, USA. Email: [email protected]. Provenance: This is an invited Editorial commissioned by Section Editor Dr. Ang Li (Department of General Surgery, Xuanwu Hospital Capital Medical University, Beijing 100053, China). Comment on: Hackert T, Probst P, Knebel P, et al. Pylorus Resection Does Not Reduce Delayed Gastric Emptying After Partial Pancreatoduodenectomy: A Blinded Randomized Controlled Trial (PROPP Study, DRKS00004191). Ann Surg 2018;267:1021-7. Received: 28 February 2018; Accepted: 19 March 2018; Published: 19 July 2018. doi: 10.21037/dmr.2018.07.04 View this article at: http://dx.doi.org/10.21037/dmr.2018.07.04 Pylorus preserving pancreaticoduodenectomy (PPPD) incidences (5). has been popularized as the surgical approach for patients As the currently largest, randomized controlled trial, with periampullary lesions by Traverso and Longmire PROPP study included 188 patients with statistical since 1978 (1). It was first hypothesized to reduce the superiority hypothesis (pylorus resection is associated occurrence of dumping, diarrhea, bile reflux gastritis and with less DGE than pylorus preservation). In the control improve overall nutritional status compared with classic group, duodenum was divided 2 cm distal to the pylorus. pancreaticoduodenectomy, also known as classic Whipple An antecolic end-to-side (ETS) duodenojejunostomy (CW). Based on the Cochrane database review in 2016, was performed 50 cm distal to the hepaticojejunostomy.
    [Show full text]
  • Vomiting in Children
    Vomiting in Children T. Matthew Shields, MD,* Jenifer R. Lightdale, MD, MPH* *Division of Pediatric Gastroenterology and Nutrition, UMass Memorial Children’s Medical Center, Department of Pediatrics, University of Massachusetts Medical School, Worcester, MA Education Gaps 1. There are at least 4 known physiologic pathways that can trigger vomiting, 3 of which are extraintestinal. 2. Understanding which pathway is causing a patient’s vomiting will help determine best treatment options, including which antiemetic is most likely to be helpful to mitigate symptoms. 3. Bilious emesis in a newborn should indicate bowel obstruction. 4. Cyclic episodes of vomiting may be indicative of a migraine variant. Objectives After completing this article, readers should be able to: 1. Understand the main pathways that trigger vomiting via the emetic reflex. 2. Differentiate among acute, chronic, and cyclic causes of vomiting. 3. Create a broad differential diagnosis for vomiting based on a patient’s history, physical examination findings, and age. 4. Recognize red flag signs and symptoms of vomiting that require emergent evaluation. 5. Recognize when to begin an antiemetic medication. AUTHOR DISCLOSURE Dr Shields has 6. Select antiemetic medications according to the presumed underlying disclosed no financial relationships relevant to this article. Dr Lightdale has disclosed that she mechanism of vomiting. has a research grant from AbbVie and receives honorarium as a speaker for Mead Johnson. This commentary does not contain a discussion of an unapproved/investigative use of a commercial product/device. Vomiting is a common symptom of numerous underlying conditions for which children frequently present for healthcare. Although vomiting can originate from ABBREVIATIONS the gastrointestinal (GI) tract itself, it can also signal more generalized, systemic 5-HT 5-hydroxytryptamine disorders.
    [Show full text]
  • Journal of Pediatric Surgery Case Reports 40 (2019) 71–75
    Journal of Pediatric Surgery Case Reports 40 (2019) 71–75 Contents lists available at ScienceDirect Journal of Pediatric Surgery Case Reports journal homepage: www.elsevier.com/locate/epsc Laparoscopic resection of pancreatic neck lesion with Roux-en-Y T pancreatico-jejunostomy ∗ ∗ Martin Sidlera, , Pratik Shahb, Michael Ashworthc, Paolo De Coppia, a Specialist Neonatal and Paediatric Surgery, Great Ormond Street Hospital, London, United Kingdom b Paediatric Endocrinology, Great Ormond Street Hospital, London, United Kingdom c Paediatric Histopathology, Great Ormond Street Hospital, London, United Kingdom ABSTRACT Background: Congenital hyperinsulinism is a rare disease and patients not re- sponding to medical treatment need near-total or partial pancreatectomy, dependent on whether they have diffuse or focal hyperinsulinism, respectively. While laparoscopic technique for distal and for total pancreatectomy has been developed, minimally invasive resection of the pancreatic neck with pancreatico-jejunostomy has not been reported in children before. Case summary: A 2-year old boy suffered from congenital hyperinsulinism, which was refractory to high-dose medical treatment. The nuclear-medicine scanrevealed a focal lesion of the pancreatic neck, hence partial pancreatectomy was indicated. On laparoscopy, a slightly prominent tissue mass was apparent in the area of the pancreatic neck. We proceeded with laparoscopic mobilisation of the pancreas from the underlying splenic vessels and resected the pancreatic neck and adjacent parts of the body and the head. After macroscopic resection of the mass, the patient's intraoperative blood glucose levels increased to a point where insulin had to be substituted. To drain the pancreatic tail, we formed an end-to-side anastomosis in the proximal Jejunum and brought the open end to the pancreatic tail and performed a laparoscopic pancreatico-jejunostomy.
    [Show full text]
  • Gastroparesis and Dumping Syndrome: Current Concepts and Management
    Journal of Clinical Medicine Review Gastroparesis and Dumping Syndrome: Current Concepts and Management Stephan R. Vavricka 1,2,* and Thomas Greuter 2 1 Center of Gastroenterology and Hepatology, CH-8048 Zurich, Switzerland 2 Department of Gastroenterology and Hepatology, University Hospital Zurich, CH-8091 Zurich, Switzerland * Correspondence: [email protected] Received: 21 June 2019; Accepted: 23 July 2019; Published: 29 July 2019 Abstract: Gastroparesis and dumping syndrome both evolve from a disturbed gastric emptying mechanism. Although gastroparesis results from delayed gastric emptying and dumping syndrome from accelerated emptying of the stomach, the two entities share several similarities among which are an underestimated prevalence, considerable impairment of quality of life, the need for a multidisciplinary team setting, and a step-up treatment approach. In the following review, we will present an overview of the most important clinical aspects of gastroparesis and dumping syndrome including epidemiology, pathophysiology, presentation, and diagnostics. Finally, we highlight promising therapeutic options that might be available in the future. Keywords: gastroparesis; dumping syndrome; pathophysiology; clinical presentation; treatment 1. Introduction Gastroparesis and dumping syndrome both evolve from a disturbed gastric emptying mechanism. While gastroparesis results from significantly delayed gastric emptying, dumping syndrome is a consequence of increased flux of food into the small bowel [1,2]. The two entities share several important similarities: (i) gastroparesis and dumping syndrome are frequent, but also frequently overlooked; (ii) they affect patient’s quality of life considerably due to possibly debilitating symptoms; (iii) patients should be taken care of within a multidisciplinary team setting; and (iv) treatment should follow a step-up approach from dietary modifications and patient education to pharmacological interventions and, finally, surgical procedures and/or enteral feeding.
    [Show full text]
  • Endoscopic Approaches to Gastroparesis
    Endoscopic Approaches to Gastroparesis Kevin Liu, MD,1 Thomas Enke, MD,2 and Aziz Aadam, MD1 1Division of Gastroenterology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 2Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois Corresponding author: Abstract: Gastroparesis is a complex syndrome with multiple Dr Aziz Aadam underlying etiologies and pathophysiologies that can cause signif- 676 North Saint Clair St, Suite 1400 icant morbidity for patients. Currently, there are limited effective Chicago, IL 60611 and durable medical and surgical treatments for patients with Tel: (312) 695-3364 E-mail: [email protected] gastroparesis. As such, there has been recent innovation and development in minimally invasive endoscopic treatments for gastroparesis. Endoscopic therapies that have been investigated for gastroparesis include enteral feeding tube placement, intrapyloric botulinum toxin injection, transpyloric stenting, gastric peroral endoscopic myotomy, and gastric electrical stimulation. This article aims to assess the effectiveness of current endoscopic therapies, as well as discuss future directions for endoscopic therapies, in the management of gastroparesis. astroparesis is defined as a complex syndrome of symp- toms, including early satiety, postprandial fullness, nausea, vomiting, bloating, and upper abdominal pain, with a Gcorresponding objective delay in gastric emptying in the absence of mechanical obstruction.1 The primary etiologies
    [Show full text]
  • Laparoscopic Vs. Open Pyloromyotomy in Treatment of Infantile Hypertrophic Pyloric Stenosis
    ORIGINAL RESEARCH published: 21 August 2020 doi: 10.3389/fped.2020.00426 Laparoscopic vs. Open Pyloromyotomy in Treatment of Infantile Hypertrophic Pyloric Stenosis Ibrahim Ismail, Radi Elsherbini, Adham Elsaied, Kamal Aly and Hesham Sheir* Pediatric Surgery Department, Mansoura University Chlidren Hospital, Mansoura University, Mansoura, Egypt Background/Purpose: Laparoscopic pyloromyotomy gained wide popularity in management of pyloric stenosis with contradictory results regarding its benefits over classic open approach. This study aimed at comparing both regarding their safety, efficiency, and outcome. Methods: This is a prospective randomized controlled study performed from April 2017 to April 2019. It included 80 patients, divided randomly into two groups, where laparoscopic pyloromyotomy was performed in group A and open pyloromyotomy Edited by: in group B. Both groups were compared regarding operative time, post-operative Henri Steyaert, pain score, time required to reach full feeding, hospital stay, complications, and Queen Fabiola Children’s University Hospital, Belgium parents’ satisfaction. Reviewed by: Results: Median operative time was 21 min in group A vs. 30 min in group B (P = 0). Oliver J. Muensterer, Johannes Gutenberg University Pain Assessment in Neonates scores were generally higher in group B with more doses Mainz, Germany of analgesics required (P = 0). Mean time needed to reach full feeding was 15.2 and Matthijs Oomen, 18.8 h in groups A and B, respectively (P = 0). Median hospital stay was 19 h in group Amsterdam University Medical Centers – AMC, Netherlands A and 22 h in group B (P = 0.004). Parents’ satisfaction also was in favor of group *Correspondence: A (P = 0.045). Although no significant difference was reported between both groups Hesham Sheir regarding early and late complications, some complications such as mucosal perforation [email protected] and incomplete pyloromyotomy occurred in the laparoscopic group only.
    [Show full text]
  • Rheumatoide Arthritis Im Mausmodell - Immunologische Und Strukturelle Verän- Derungen Im Darm
    Rheumatoide Arthritis im Mausmodell - immunologische und strukturelle Verän- derungen im Darm in Medizin 3 Rheumatologie/ Immunologie des Universitätsklinikums Erlangen Klinikdirektor: Prof. Dr. med. univ. Georg Schett Dissertation der Medizinischen Fakultät der Friedrich-Alexander-Universität Erlangen-Nürnberg zur Erlangung des Doktorgrades Dr. med. vorgelegt von Oscar Theodor Schulz aus Burgwedel Als Dissertation genehmigt von der Medizinischen Fakultät der Friedrich-Alexander-Universität Erlangen-Nürnberg Vorsitzender des Promotionsorgans: Prof. Dr. Markus F Neurath Gutachter: Prof. Dr. Mario Zaiss Gutachter: Prof. Dr. Gerhard Krönke Tag der mündlichen Prüfung: 16. März 2021 Inhaltsverzeichnis 1. Zusammenfassung / Abstract ...................................................................... - 1 - 1.1.1 Hintergrund und Ziele ......................................................................... - 1 - 1.1.2 Methoden (Patienten, Material und Untersuchungsmethoden) .......... - 1 - 1.1.3 Ergebnisse und Beobachtungen ......................................................... - 2 - 1.1.4 Schlussfolgerung ................................................................................ - 3 - 1.2.1 Background and aims ......................................................................... - 4 - 1.2.2 Methods (patients, material and examination methods) ..................... - 4 - 1.2.3 Results ................................................................................................ - 5 - 1.3.4 Conclusion .........................................................................................
    [Show full text]
  • Naiyana Gujral
    University of Alberta ANTIBODY-BASED DIAGNOSTIC AND THERAPEUTIC APPROACHES ON GLUTEN-SENSITIVE ENTEROPATHY by Naiyana Gujral A thesis submitted to the Faculty of Graduate Studies and Research in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Pharmaceutical Sciences Faculty of Pharmacy and Pharmaceutical Sciences © Naiyana Gujral Fall 2013 Edmonton, Alberta Permission is hereby granted to the University of Alberta Libraries to reproduce single copies of this thesis and to lend or sell such copies for private, scholarly or scientific research purposes only. Where the thesis is converted to, or otherwise made available in digital form, the University of Alberta will advise potential users of the thesis of these terms. The author reserves all other publication and other rights in association with the copyright in the thesis and, except as herein before provided, neither the thesis nor any substantial portion thereof may be printed or otherwise reproduced in any material form whatsoever without the author's prior written permission. DEDICATION I dedicate this thesis to my beloved family with all my love respect, and gratitude. ABSTRACT Gluten-sensitive enteropathy, called Celiac disease (CD), is one of the most frequent autoimmune diseases, occurring in 1% people worldwide, upon gliadin ingestion. Currently, the only treatment available for CD individual is a strict life-long gluten-free diet. Chicken egg yolk immunoglobulin Y (IgY) is produced and examined for its efficacy in vitro, ex vivo, and in vivo to prevent enteric absorption of gliadin. This antibody was also used to develop sensitive and rapid detection kits for gluten. The extracted toxic gliadin was immunized into chickens inducing humoral immune response to produced gliadin-specific IgY antibodies.
    [Show full text]
  • Endoscopic Pyloromyotomy for Postesopha- Gectomy Gastric Outlet Obstruction
    Cases and Techniques Library (CTL) E345 Endoscopic pyloromyotomy for postesopha- gectomy gastric outlet obstruction Fig. 1 A 54-year-old woman presented with vomiting 2 weeks after esophagectomy with gastric pull-up. a Esophagography revealed marked delay in passage of contrast through the pylorus. b Fluid retention was noted on esophago- gastroduodenoscopy (EGD) and the scope could not be passed through the pylorus. Postesophagectomy gastric outlet ob- vomiting. Esophagogastroduodenoscopy The mucosal entry was then closed using struction occurs in 20% –30% of patients (EGD) revealed significant food stasis in four endoscopic clips (●" Video 1). who undergo esophagectomy and is asso- the pulled-up stomach and again the en- On the following day, fluoroscopy showed ciated with significant morbidity and de- doscope could not be passed through the significant improvement in passage of layed recovery [1]. Recently, endoscopic pylorus. contrast (●" Fig. 3) and the gastroscope pyloromyotomy, also called gastric per- Endoscopic pyloromyotomy was per- (GIF-H260; Olympus) could pass smooth- oral endoscopic myotomy (POEM), has formed with the patient under conscious ly through the pylorus. The patient was been reported, in pigs and in a patient sedation. Saline solution mixed with indi- started on a liquid diet and was dis- with refractory diabetic gastroparesis [2, go carmine was injected on the greater charged the next day. She remains well 3]. We report a case of postesophagec- curvature 5cm proximal to the pylorus. A 10 weeks after the procedure and appro- tomy delayed gastric emptying that was 1.5-cm mucosal incision was made priately tolerates a general diet. successfully treated with endoscopic (●" Fig.2) using a DualKnife (KD-650L; pyloromyotomy.
    [Show full text]
  • The Pennsylvania State University the Graduate School College Of
    The Pennsylvania State University The Graduate School College of Agricultural Sciences PHYSICOCHEMICAL MODIFICATION OF GLIADIN BY DIETARY POLYPHENOLS AND THE POTENTIAL IMPLICATIONS FOR CELIAC DISEASE A Dissertation in Food Science by Charlene B. Van Buiten © 2017 Charlene B. Van Buiten Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy August 2017 The dissertation of Charlene B. Van Buiten was reviewed and approved* by the following: Ryan J. Elias Associate Professor of Food Science Dissertation Advisor Chair of Committee Joshua D. Lambert Associate Professor of Food Science John N. Coupland Professor of Food Science Gregory R. Ziegler Professor of Food Science Connie J. Rogers Associate Professor of Nutritional Sciences Robert F. Roberts Professor of Food Science Head of the Department of Food Science *Signatures are on file in the Graduate School ii ABSTRACT Celiac disease is an autoimmune enteropathy that affects approximately 1% of the world population. Characterized by an adverse reaction to gluten protein, celiac disease manifests in the small bowel and results in inflammation and increased permeability of the gut barrier. This is followed by an immune response mounted against not only gluten, but also tissue transglutaminase 2 (TG2), a gluten-reactive enzyme secreted by intestinal epithelial cells. Despite the growing number of individuals affected by this disease, the only reliable intervention strategy available is lifelong adherence to a gluten-free diet. Novel strategies for treating or preventing celiac disease include synthetic pharmaceuticals to modify the gut barrier, parabiotic infection to reduce inflammatory cytokine release and administration of a synthetic polymer that binds gluten proteins and prevents their digestion and absorption.
    [Show full text]
  • Multisystem Inflammatory Syndrome in Children Is Driven by Zonulin-Dependent Loss of Gut Mucosal Barrier
    The Journal of Clinical Investigation CLINICAL MEDICINE Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier Lael M. Yonker,1,2,3 Tal Gilboa,3,4,5 Alana F. Ogata,3,4,5 Yasmeen Senussi,4 Roey Lazarovits,4,5 Brittany P. Boribong,1,2,3 Yannic C. Bartsch,3,6 Maggie Loiselle,1 Magali Noval Rivas,7 Rebecca A. Porritt,7 Rosiane Lima,1 Jameson P. Davis,1 Eva J. Farkas,1 Madeleine D. Burns,1 Nicola Young,1 Vinay S. Mahajan,3,6 Soroush Hajizadeh,3,8 Xcanda I. Herrera Lopez,3,8 Johannes Kreuzer,3,8 Robert Morris,3,8 Enid E. Martinez,1,3,9 Isaac Han,3,5 Kettner Griswold Jr.,3,5 Nicholas C. Barry,3,5 David B. Thompson,3,5 George Church,3,5,10 Andrea G. Edlow,3,11,12 Wilhelm Haas,3,8 Shiv Pillai,3,6 Moshe Arditi,7 Galit Alter,3,6 David R. Walt,3,4,5 and Alessio Fasano1,2,3,13 1Mucosal Immunology and Biology Research Center and 2Department of Pediatrics, Massachusetts General Hospital, Boston, Massachusetts, USA. 3Harvard Medical School, Boston, Massachusetts, USA. 4Department of Pathology, Brigham and Women’s Hospital, Boston, Massachusetts, USA. 5Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, USA. 6Ragon Institute of MIT, MGH and Harvard, Cambridge, Massachusetts, USA. 7Department of Pediatrics, Division of Infectious Diseases and Immunology, Infectious and Immunologic Diseases Research Center (IIDRC) and Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA. 8Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.
    [Show full text]
  • Basic Surgical Techniques
    BASIC SURGICAL TECHNIQUES Textbook Authors: György Wéber MD, PhD, med. habil. János Lantos MSc, PhD Balázs Borsiczky MD, PhD Andrea Ferencz MD, PhD Gábor Jancsó MD, PhD Sándor Ferencz MD Szabolcs Horváth MD Hossein Haddadzadeh Bahri MD Ildikó Takács MD Borbála Balatonyi MD University of Pécs, Medical School Department of Surgical Research and Techniques 20 Kodály Zoltán Steet, H-7624 Pécs, Telephone: +36 72 535 820 Website:http://soki.aok.pte.hu 2008 1 PREFACE The healing is impossible without entering into suffering people’s feelings and to humble yourself in your profession. All these are completed by the ability to manage the immediate and critical situations dynamically and to analyze the diseases interdisciplinarily (e.g. diagnosis, differential diagnosis, appropriate decision among the alternative possibilities of treatment, etc.). A successful surgical intervention requires even more than this. It needs the perfect, aimful and economical coordination of operational movements. The refined technique of the handling and uniting the tissues –in the case of manual skills– is attainable by many practices, and the good surgeon works on the perfection of this technique in his daily operating activities. The most important task in the medical education is to teach the problem-oriented thinking and the needed practical ability. The graduate medical student will notice in a short time that a medical practitioner principally needs the practical knowledge and manual skill in provision for the sick. “The surgical techniques” is a popular subJect. It is a subJect in which the medical students -for the first time- will see the inside of the living and pulsating organism.
    [Show full text]